TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs420259
log Bayes Factor = 0.101125
Chromosome 16   position 23,634,026  (GRCh37) Explore rs420259 on Ensembl!
Variant rs420259 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Showing all nodes without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
Z45.2 Adjustment and management of vascular access device
0.285 0.715 0.000
Z45 Adjustment and management of implanted device
0.201 0.799 0.000
Z45.1 Adjustment and management of infusion pump
0.185 0.815 0.000
Z45.8 Adjustment and management of other implanted devices
0.171 0.829 0.000
Z45.9 Adjustment and management of unspecified implanted device
0.157 0.843 0.000
Z45.3 Adjustment and management of implanted hearing device
0.147 0.853 0.000
Z45.0 Adjustment and management of cardiac pacemaker
0.058 0.942 0.000
C18.6 Descending colon
0.036 0.964 0.000
C18.9 Colon, unspecified
0.032 0.968 0.000
C20 Malignant neoplasm of rectum
0.031 0.969 0.000
C18 Malignant neoplasm of colon
0.030 0.970 0.000
C18.3 Hepatic flexure
0.029 0.971 0.000
Y86 Sequelae of other accidents
0.026 0.974 0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified
0.025 0.975 0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma
0.024 0.976 0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type
0.024 0.976 0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma
0.024 0.976 0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue
0.024 0.976 0.000
C18.8 Overlapping lesion of colon
0.023 0.977 0.000
C15-C26 Malignant neoplasms of digestive organs
0.023 0.977 0.000
C85.7 Other specified types of non-Hodgkin's lymphoma
0.022 0.978 0.000
C26 Malignant neoplasm of other and ill-defined digestive organs
0.022 0.978 0.000
C26.0 Intestinal tract, part unspecified
0.021 0.979 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.021 0.979 0.000
C95 Leukaemia of unspecified cell type
0.020 0.980 0.000
C82.2 Large cell, follicular
0.020 0.980 0.000
C18.0 Caecum
0.020 0.980 0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma
0.019 0.980 0.000
C83.0 Small cell (diffuse)
0.019 0.981 0.000
C82.4 Follicular lymphoma grade IIIb
0.019 0.981 0.000
C86 Other specified types of T/NK-cell lymphoma
0.019 0.981 0.000
C23 Malignant neoplasm of gallbladder
0.019 0.981 0.000
C81 Hodgkin's disease
0.019 0.981 0.000
C18.5 Splenic flexure
0.019 0.981 0.000
C93 Monocytic leukaemia
0.018 0.982 0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma
0.018 0.982 0.000
C85.0 Lymphosarcoma
0.018 0.982 0.000
C82.6 Cutaneous follicle centre lymphoma
0.017 0.982 0.000
C82.5 Diffuse follicle centre lymphoma
0.017 0.982 0.000
C82.0 Small cleaved cell, follicular
0.017 0.983 0.000
C95.9 Leukaemia, unspecified
0.017 0.983 0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.017 0.983 0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.017 0.983 0.000
C94 Other leukaemias of specified cell type
0.017 0.983 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.017 0.983 0.000
C84 Peripheral and cutaneous T-cell lymphomas
0.017 0.983 0.000
C18.2 Ascending colon
0.017 0.983 0.000
C24 Malignant neoplasm of other and unspecified parts of biliary tract
0.017 0.983 0.000
C17 Malignant neoplasm of small intestine
0.017 0.983 0.000
C82.1 Mixed small cleaved and large cell, follicular
0.016 0.984 0.000
C18.1 Appendix
0.016 0.984 0.000
C81.1 Nodular sclerosis
0.016 0.984 0.000
C26.8 Overlapping lesion of digestive system
0.016 0.984 0.000
C26.1 Spleen
0.016 0.984 0.000
C19 Malignant neoplasm of rectosigmoid junction
0.016 0.984 0.000
D48.5 Skin
0.016 0.984 0.000
C81.0 Lymphocytic predominance
0.016 0.984 0.000
D75.8 Other specified diseases of blood and blood-forming organs
0.016 0.984 0.000
C86.5 Angioimmunoblastic T-cell lymphoma
0.015 0.985 0.000
D48.6 Breast
0.015 0.985 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.015 0.985 0.000
C83.6 Undifferentiated (diffuse)
0.015 0.985 0.000
C83.5 Lymphoblastic (diffuse)
0.015 0.985 0.000
C83.4 Immunoblastic (diffuse)
0.015 0.985 0.000
C83.2 Mixed small and large cell (diffuse)
0.015 0.985 0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites
0.015 0.985 0.000
C26.9 Ill-defined sites within the digestive system
0.015 0.985 0.000
C95.7 Other leukaemia of unspecified cell type
0.014 0.985 0.000
C95.2 Subacute leukaemia of unspecified cell type
0.014 0.985 0.000
C95.1 Chronic leukaemia of unspecified cell type
0.014 0.985 0.000
C95.0 Acute leukaemia of unspecified cell type
0.014 0.985 0.000
C83.1 Small cleaved cell (diffuse)
0.014 0.985 0.000
C82.3 Follicular lymphoma grade IIIa
0.014 0.986 0.000
C02 Malignant neoplasm of other and unspecified parts of tongue
0.014 0.986 0.000
C17.9 Small intestine, unspecified
0.014 0.986 0.000
Z22.5 Carrier of viral hepatitis
0.014 0.986 0.000
C90.3 Solitary plasmacytoma
0.014 0.986 0.000
C83.7 Burkitt's tumour
0.014 0.986 0.000
C92 Myeloid leukaemia
0.014 0.986 0.000
C93.1 Chronic monocytic leukaemia
0.014 0.986 0.000
Z22 Carrier of infectious disease
0.014 0.986 0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations
0.014 0.986 0.000
C86.4 Blastic NK-cell lymphoma
0.014 0.986 0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma
0.014 0.986 0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma
0.014 0.986 0.000
C86.1 Hepatosplenic T-cell lymphoma
0.014 0.986 0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type
0.014 0.986 0.000
C81.7 Other Hodgkin's disease
0.014 0.986 0.000
C81.4 Lymphocyte-rich classical Hodgkin lymphoma
0.014 0.986 0.000
C81.3 Lymphocytic depletion
0.014 0.986 0.000
Z22.3 Carrier of other specified bacterial diseases
0.014 0.986 0.000
D75 Other diseases of blood and blood-forming organs
0.014 0.986 0.000
C24.1 Ampulla of Vater
0.013 0.987 0.000
C88 Malignant immunoproliferative diseases
0.013 0.987 0.000
C81.2 Mixed cellularity
0.013 0.987 0.000
C93.9 Monocytic leukaemia, unspecified
0.013 0.987 0.000
C93.7 Other monocytic leukaemia
0.013 0.987 0.000
C93.3 Juvenile myelomonocytic leukaemia
0.013 0.987 0.000
C93.2 Subacute monocytic leukaemia
0.013 0.987 0.000
C93.0 Acute monocytic leukaemia
0.013 0.987 0.000
M16.0 Primary coxarthrosis, bilateral
0.000 0.987 0.013
C84.0 Mycosis fungoides
0.013 0.987 0.000
C83.3 Large cell (diffuse)
0.013 0.987 0.000
C02.2 Ventral surface of tongue
0.013 0.987 0.000
C02.4 Lingual tonsil
0.013 0.987 0.000
B02.9 Zoster without complication
0.013 0.987 0.000
C24.9 Biliary tract, unspecified
0.013 0.987 0.000
C02.1 Border of tongue
0.013 0.987 0.000
C94.7 Other specified leukaemias
0.012 0.987 0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified
0.012 0.987 0.000
C94.5 Acute myelofibrosis
0.012 0.987 0.000
C94.4 Acute panmyelosis
0.012 0.987 0.000
C94.3 Mast cell leukaemia
0.012 0.987 0.000
C94.2 Acute megakaryoblastic leukaemia
0.012 0.987 0.000
C94.1 Chronic erythraemia
0.012 0.987 0.000
C94.0 Acute erythraemia and erythroleukaemia
0.012 0.987 0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified
0.012 0.987 0.000
C96.8 Histiocytic sarcoma
0.012 0.987 0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue
0.012 0.987 0.000
C96.6 Unifocal Langerhans-cell histiocytosis
0.012 0.987 0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis
0.012 0.987 0.000
C96.4 Sarcoma of dendritic cells (accessory cells)
0.012 0.987 0.000
C96.3 True histiocytic lymphoma
0.012 0.987 0.000
C96.2 Malignant mast cell tumour
0.012 0.987 0.000
C96.1 Malignant histiocytosis
0.012 0.987 0.000
C96.0 Letterer-Siwe disease
0.012 0.987 0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx
0.013 0.987 0.000
C90.2 Plasmacytoma, extramedullary
0.012 0.988 0.000
C84.4 Peripheral T-cell lymphoma
0.012 0.988 0.000
D75.0 Familial erythrocytosis
0.012 0.988 0.000
C02.9 Tongue, unspecified
0.012 0.988 0.000
C84.9 Mature T/NK-cell lymphoma, unspecified
0.012 0.988 0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative
0.012 0.988 0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive
0.012 0.988 0.000
C84.3 Lymphoepithelioid lymphoma
0.012 0.988 0.000
C84.2 T-zone lymphoma
0.012 0.988 0.000
C84.1 Sezary's diease
0.012 0.988 0.000
C84.8 Cutaneous T-cell lymphoma, unspecified
0.012 0.988 0.000
C24.8 Overlapping lesion of biliary tract
0.012 0.988 0.000
Chapter II Neoplasms
0.012 0.988 0.000
C17.8 Overlapping lesion of small intestine
0.012 0.988 0.000
C17.3 Meckel's diverticulum
0.012 0.988 0.000
D03.6 Melanoma in situ of upper limb, including shoulder
0.012 0.988 0.000
D75.1 Secondary polycythaemia
0.012 0.988 0.000
C85.1 B-cell lymphoma, unspecified
0.012 0.988 0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified
0.012 0.988 0.000
C17.0 Duodenum
0.012 0.988 0.000
D03 Melanoma in situ
0.012 0.988 0.000
Z22.8 Carrier of other infectious diseases
0.012 0.988 0.000
C92.4 Acute promyelocytic leukaemia
0.012 0.988 0.000
C17.1 Jejunum
0.011 0.988 0.000
C90.0 Multiple myeloma
0.012 0.988 0.000
D48.1 Connective and other soft tissue
0.011 0.989 0.000
C90.1 Plasma cell leukaemia
0.011 0.989 0.000
C21 Malignant neoplasm of anus and anal canal
0.011 0.989 0.000
Z29.2 Other prophylactic chemotherapy
0.011 0.989 0.000
D00-D09 In situ neoplasms
0.011 0.989 0.000
D48.4 Peritoneum
0.011 0.989 0.000
D48.3 Retroperitoneum
0.011 0.989 0.000
C79 Secondary malignant neoplasm of other sites
0.011 0.989 0.000
C84.5 Other and unspecified T-cell lymphomas
0.011 0.989 0.000
C79.8 Secondary malignant neoplasm of other specified sites
0.011 0.989 0.000
D48.7 Other specified sites
0.011 0.989 0.000
C06 Malignant neoplasm of other and unspecified parts of mouth
0.011 0.989 0.000
D37-D48 Neoplasms of uncertain or unknown behaviour
0.011 0.989 0.000
C02.8 Overlapping lesion of tongue
0.010 0.989 0.000
C02.3 Anterior two-thirds of tongue, part unspecified
0.010 0.989 0.000
C02.0 Dorsal surface of tongue
0.010 0.989 0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands
0.011 0.989 0.000
D70 Agranulocytosis
0.011 0.989 0.000
C01 Malignant neoplasm of base of tongue
0.010 0.990 0.000
D70-D77 Other diseases of blood and blood-forming organs
0.010 0.990 0.000
C79.3 Secondary malignant neoplasm of brain and cerebral meninges
0.010 0.990 0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia
0.010 0.990 0.000
C92.6 Acute myeloid leukaemia with 11q23-abnormality
0.010 0.990 0.000
C92.5 Acute myelomonocytic leukaemia
0.010 0.990 0.000
C92.3 Myeloid sarcoma
0.010 0.990 0.000
C92.2 Subacute myeloid leukaemia
0.010 0.990 0.000
Z29 Need for other prophylactic measures
0.010 0.990 0.000
C91 Lymphoid leukaemia
0.010 0.990 0.000
C92.9 Myeloid leukaemia, unspecified
0.010 0.990 0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis
0.010 0.990 0.000
C24.0 Extrahepatic bile duct
0.010 0.990 0.000
Z22.9 Carrier of infectious disease, unspecified
0.010 0.990 0.000
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection
0.010 0.990 0.000
Z22.4 Carrier of infections with a predominantly sexual mode of transmission
0.010 0.990 0.000
Z22.2 Carrier of diphtheria
0.010 0.990 0.000
Z22.0 Carrier of typhoid
0.010 0.990 0.000
D03.7 Melanoma in situ of lower limb, including hip
0.010 0.990 0.000
Z20-Z29 Persons with potential health hazards related to communicable diseases
0.010 0.990 0.000
D07 Carcinoma in situ of other and unspecified genital organs
0.010 0.990 0.000
D07.1 Vulva
0.010 0.990 0.000
D48.0 Bone and articular cartilage
0.010 0.990 0.000
C17.2 Ileum
0.010 0.990 0.000
D48.2 Peripheral nerves and autonomic nervous system
0.010 0.990 0.000
J02.9 Acute pharyngitis, unspecified
0.000 0.990 0.010
C13 Malignant neoplasm of hypopharynx
0.010 0.990 0.000
S27 Injury of other and unspecified intrathoracic organs
0.010 0.990 0.000
D03.5 Melanoma in situ of trunk
0.010 0.990 0.000
C11 Malignant neoplasm of nasopharynx
0.010 0.990 0.000
C92.7 Other myeloid leukaemia
0.010 0.990 0.000
C79.9 Secondary malignant neoplasm, unspecified site
0.010 0.990 0.000
C88.9 Malignant immunoproliferative disease, unspecified
0.009 0.990 0.000
C88.7 Other malignant immunoproliferative diseases
0.009 0.990 0.000
C88.3 Immunoproliferative small intestinal disease
0.009 0.990 0.000
C88.2 Gamma heavy chain disease
0.009 0.990 0.000
C88.1 Alpha heavy chain disease
0.009 0.990 0.000
C76-C80 Malignant neoplasms of ill-defined, secondary and unspecified sites
0.010 0.990 0.000
C16 Malignant neoplasm of stomach
0.010 0.990 0.000
C73 Malignant neoplasm of thyroid gland
0.010 0.990 0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites
0.010 0.990 0.000
C81.9 Hodgkin's disease, unspecified
0.010 0.990 0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs
0.010 0.990 0.000
S27.30 Other injuries of lung (without open wound into thoracic cavity)
0.010 0.990 0.000
S27.3 Other injuries of lung
0.010 0.990 0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)
0.010 0.990 0.000
S27.2 Traumatic heamopneumothorax
0.009 0.990 0.000
D03.8 Melanoma in situ of other sites
0.009 0.991 0.000
D03.4 Melanoma in situ of scalp and neck
0.009 0.991 0.000
C10 Malignant neoplasm of oropharynx
0.009 0.991 0.000
C07 Malignant neoplasm of parotid gland
0.009 0.991 0.000
C06.9 Mouth, unspecified
0.009 0.991 0.000
C03 Malignant neoplasm of gum
0.009 0.991 0.000
D76 Certain diseases involving lymphoreticular tissue and reticulohistiocytic system
0.009 0.991 0.000
C06.0 Cheek mucosa
0.009 0.991 0.000
C05 Malignant neoplasm of palate
0.009 0.991 0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx
0.009 0.991 0.000
D46 Myelodysplastic syndromes
0.009 0.991 0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]
0.009 0.991 0.000
C08 Malignant neoplasm of other and unspecified major salivary glands
0.009 0.991 0.000
D03.9 Melanoma in situ, unspecified
0.009 0.991 0.000
D03.1 Melanoma in situ of eyelid, including canthus
0.009 0.991 0.000
D03.0 Melanoma in situ of lip
0.009 0.991 0.000
C92.0 Acute myeloid leukaemia
0.009 0.991 0.000
C79.6 Secondary malignant neoplasm of ovary
0.009 0.991 0.000
S27.0 Traumatic pneumothorax
0.009 0.991 0.000
D07.4 Penis
0.008 0.991 0.000
Z22.1 Carrier of other intestinal infectious diseases
0.008 0.991 0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs
0.008 0.991 0.000
C91.9 Lymphoid leukaemia, unspecified
0.008 0.991 0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach
0.008 0.991 0.000
D01 Carcinoma in situ of other and unspecified digestive organs
0.008 0.992 0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands
0.008 0.992 0.000
C00 Malignant neoplasm of lip
0.008 0.992 0.000
C21.2 Cloacogenic zone
0.008 0.992 0.000
Z29.8 Other specified prophylactic measures
0.008 0.992 0.000
D73 Diseases of spleen
0.008 0.992 0.000
C16.1 Fundus of stomach
0.008 0.992 0.000
Z24 Need for immunisation against certain single viral diseases
0.008 0.992 0.000
D76.3 Other histiocytosis syndromes
0.008 0.992 0.000
D03.2 Melanoma in situ of ear and external auricular canal
0.008 0.992 0.000
D73.9 Disease of spleen, unspecified
0.008 0.992 0.000
S27.1 Traumatic haemothorax
0.008 0.992 0.000
C40-C41 Malignant neoplasms of bone and articular cartilage
0.008 0.992 0.000
C76 Malignant neoplasm of other and ill-defined sites
0.008 0.992 0.000
D40.0 Prostate
0.008 0.992 0.000
S27.8 Injury of other specified intrathoracic organs
0.008 0.992 0.000
C12 Malignant neoplasm of pyriform sinus
0.008 0.992 0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth
0.008 0.992 0.000
C06.1 Vestibule of mouth
0.008 0.992 0.000
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)
0.008 0.992 0.000
C92.1 Chronic myeloid leukaemia
0.008 0.992 0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges
0.008 0.992 0.000
C13.9 Hypopharynx, unspecified
0.008 0.992 0.000
D75.2 Essential thrombocytosis
0.008 0.992 0.000
Z29.0 Isolation
0.008 0.992 0.000
C75 Malignant neoplasm of other endocrine glands and related structures
0.008 0.992 0.000
C91.0 Acute lymphoblastic leukaemia
0.008 0.992 0.000
C11.9 Nasopharynx, unspecified
0.008 0.992 0.000
D74 Methaemoglobinaemia
0.008 0.992 0.000
D77 Other disorders of blood and blood-forming organs in diseases classified elsewhere
0.008 0.992 0.000
D71 Functional disorders of polymorphonuclear neutrophils
0.008 0.992 0.000
C16.4 Pylorus
0.008 0.992 0.000
C04 Malignant neoplasm of floor of mouth
0.008 0.992 0.000
D07.2 Vagina
0.008 0.992 0.000
C91.8 Mature B-cell leukaemia Burkitt-type
0.008 0.992 0.000
C91.7 Other lymphoid leukaemia
0.008 0.992 0.000
C91.6 Prolymphocytic leukaemia of T-cell type
0.008 0.992 0.000
C91.3 Prolymphocytic leukaemia
0.008 0.992 0.000
C91.2 Subacute lymphocytic leukaemia
0.008 0.992 0.000
Z29.9 Prophylactic measure, unspecified
0.008 0.992 0.000
C91.5 Adult T-cell leukaemia
0.008 0.992 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.008 0.992 0.000
C21.8 Overlapping lesion of rectum, anus and anal canal
0.007 0.992 0.000
D46.7 Other myelodysplastic syndromes
0.008 0.992 0.000
D46.1 Refractory anaemia with sideroblasts
0.008 0.992 0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs
0.008 0.992 0.000
Z28 Immunisation not carried out
0.007 0.992 0.000
Z27 Need for immunisation against combinations of infectious diseases
0.007 0.992 0.000
Z26 Need for immunisation against other single infectious diseases
0.007 0.992 0.000
Z25 Need for immunisation against other single viral diseases
0.007 0.992 0.000
Z23 Need for immunisation against single bacterial diseases
0.007 0.992 0.000
D07.6 Other and unspecified male genital organs
0.007 0.992 0.000
D07.3 Other and unspecified female genital organs
0.007 0.992 0.000
D07.0 Endometrium
0.007 0.992 0.000
Z20 Contact with and exposure to communicable diseases
0.007 0.993 0.000
C74 Malignant neoplasm of adrenal gland
0.007 0.993 0.000
D46.4 Refractory anaemia, unspecified
0.007 0.993 0.000
D05.9 Carcinoma in situ of breast, unspecified
0.007 0.993 0.000
D73.3 Abscess of spleen
0.007 0.993 0.000
D05 Carcinoma in situ of breast
0.007 0.993 0.000
C30-C39 Malignant neoplasms of respiratory and intrathoracic organs
0.007 0.993 0.000
C13.8 Overlapping lesion of hypopharynx
0.007 0.993 0.000
C13.2 Posterior wall of hypopharynx
0.007 0.993 0.000
C13.1 Aryepiglottic fold, hypopharyngeal aspect
0.007 0.993 0.000
C13.0 Postcricoid region
0.007 0.993 0.000
Y85-Y89 Sequelae of external causes of morbidity and mortality
0.007 0.993 0.000
S27.9 Injury of unspecified intrathoracic organ
0.007 0.993 0.000
S27.7 Multiple injuries of intrathoracic organs
0.007 0.993 0.000
S27.6 Injury of pleura
0.007 0.993 0.000
S27.5 Injury of thoracic trachea
0.007 0.993 0.000
S27.4 Injury of bronchus
0.007 0.993 0.000
C11.8 Overlapping lesion of nasopharynx
0.007 0.993 0.000
C11.3 Anterior wall of nasopharynx
0.007 0.993 0.000
C11.2 Lateral wall of nasopharynx
0.007 0.993 0.000
C11.1 Posterior wall of nasopharynx
0.007 0.993 0.000
C11.0 Superior wall of nasopharynx
0.007 0.993 0.000
D44.7 Aortic body and other paraganglia
0.007 0.993 0.000
C16.8 Overlapping lesion of stomach
0.007 0.993 0.000
D44.4 Craniopharyngeal duct
0.007 0.993 0.000
C16.3 Pyloric antrum
0.007 0.993 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.007 0.993 0.000
C78.5 Secondary malignant neoplasm of large intestine and rectum
0.007 0.993 0.000
S27.31 Other injuries of lung (with open wound into thoracic cavity)
0.007 0.993 0.000
C05.0 Hard palate
0.007 0.993 0.000
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)
0.007 0.993 0.000
D00.0 Lip, oral cavity and pharynx
0.007 0.993 0.000
D44.6 Carotid body
0.007 0.993 0.000
D04 Carcinoma in situ of skin
0.007 0.993 0.000
C10.9 Oropharynx, unspecified
0.007 0.993 0.000
C88.0 Waldenstrom's macroglobulinaemia
0.007 0.993 0.000
C09 Malignant neoplasm of tonsil
0.007 0.993 0.000
C10.8 Overlapping lesion of oropharynx
0.007 0.993 0.000
C10.4 Branchial cleft
0.007 0.993 0.000
C10.3 Posterior wall of oropharynx
0.007 0.993 0.000
C10.2 Lateral wall of oropharynx
0.007 0.993 0.000
C10.1 Anterior surface of epiglottis
0.007 0.993 0.000
C10.0 Vallecula
0.007 0.993 0.000
D02 Carcinoma in situ of middle ear and respiratory system
0.007 0.993 0.000
Z24.5 Need for immunisation against rubella alone
0.007 0.993 0.000
S27.10 Traumatic haemothorax (without open wound into thoracic cavity)
0.007 0.993 0.000
C05.1 Soft palate
0.007 0.993 0.000
C21.1 Anal canal
0.007 0.993 0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs
0.007 0.993 0.000
C18.4 Transverse colon
0.006 0.993 0.000
C03.9 Gum, unspecified
0.007 0.993 0.000
C03.0 Upper gum
0.007 0.993 0.000
C16.5 Lesser curvature of stomach, unspecified
0.007 0.993 0.000
D76.2 Haemophagocytic syndrome, infection-associated
0.007 0.993 0.000
D76.1 Haemophagocytic lymphohistiocytosis
0.007 0.993 0.000
D76.0 Langerhans' cell histiocytosis, not elsewhere classified
0.007 0.993 0.000
C05.8 Overlapping lesion of palate
0.007 0.993 0.000
C05.2 Uvula
0.007 0.993 0.000
C78 Secondary malignant neoplasm of respiratory and digestive organs
0.007 0.993 0.000
S27.80 Injury of other specified intrathoracic organs (without open wound into thoracic cavity)
0.007 0.993 0.000
C14.8 Overlapping lesion of lip, oral cavity and pharynx
0.007 0.993 0.000
C14.2 Waldeyer's ring
0.007 0.993 0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality
0.007 0.993 0.000
D46.5 Refractory anaemia with multi-lineage dysplasia
0.007 0.993 0.000
D46.3 Refractory anaemia with excess of blasts with transformation
0.007 0.993 0.000
D46.2 Refractory anaemia with excess of blasts
0.007 0.993 0.000
D46.0 Refractory anaemia without sideroblasts, so stated
0.007 0.993 0.000
C78.2 Secondary malignant neoplasm of pleura
0.007 0.993 0.000
D41.0 Kidney
0.007 0.993 0.000
C03.1 Lower gum
0.006 0.993 0.000
C08.8 Overlapping lesion of major salivary glands
0.006 0.993 0.000
C08.1 Sublingual gland
0.006 0.993 0.000
C08.0 Submandibular gland
0.006 0.993 0.000
D09 Carcinoma in situ of other and unspecified sites
0.007 0.993 0.000
C16.6 Greater curvature of stomach, unspecified
0.006 0.993 0.000
C06.2 Retromolar area
0.006 0.993 0.000
C16.2 Body of stomach
0.006 0.993 0.000
C21.0 Anus, unspecified
0.006 0.993 0.000
D04.3 Skin of other and unspecified parts of face
0.007 0.993 0.000
C38 Malignant neoplasm of heart, mediastinum and pleura
0.007 0.993 0.000
D01.2 Rectum
0.006 0.993 0.000
D04.1 Skin of eyelid, including canthus
0.006 0.993 0.000
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)
0.006 0.993 0.000
Y87 Sequelae of intentional self-harm, assault and events of undetermined intent
0.006 0.993 0.000
C14.0 Pharynx, unspecified
0.006 0.993 0.000
C18.7 Sigmoid colon
0.007 0.993 0.000
C40 Malignant neoplasm of bone and articular cartilage of limbs
0.006 0.993 0.000
C76.2 Abdomen
0.006 0.994 0.000
D01.3 Anus and anal canal
0.006 0.994 0.000
D40.9 Male genital organ, unspecified
0.006 0.994 0.000
D40.7 Other male genital organs
0.006 0.994 0.000
C76.1 Thorax
0.006 0.994 0.000
D00.2 Stomach
0.006 0.994 0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system
0.006 0.994 0.000
C76.3 Pelvis
0.006 0.994 0.000
D01.9 Digestive organ, unspecified
0.006 0.994 0.000
D01.7 Other specified digestive organs
0.006 0.994 0.000
D01.5 Liver, gallbladder and bile ducts
0.006 0.994 0.000
D01.4 Other and unspecified parts of intestine
0.006 0.994 0.000
D01.1 Rectosigmoid junction
0.006 0.994 0.000
D01.0 Colon
0.006 0.994 0.000
D44.9 Endocrine gland, unspecified
0.006 0.994 0.000
D44.5 Pineal gland
0.006 0.994 0.000
D44.2 Parathyroid gland
0.006 0.994 0.000
D41.1 Renal pelvis
0.006 0.994 0.000
C00.9 Lip, unspecified
0.006 0.994 0.000
C00.8 Overlapping lesion of lip
0.006 0.994 0.000
C00.6 Commissure of lip
0.006 0.994 0.000
C00.5 Lip, unspecified, inner aspect
0.006 0.994 0.000
C00.4 Lower lip, inner aspect
0.006 0.994 0.000
C00.3 Upper lip, inner aspect
0.006 0.994 0.000
C00.2 External lip, unspecified
0.006 0.994 0.000
C00.1 External lower lip
0.006 0.994 0.000
Z29.1 Prophylactic immunotherapy
0.006 0.994 0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system
0.006 0.994 0.000
O69.1 Labour and delivery complicated by cord around neck, with compression
0.006 0.994 0.000
C08.9 Major salivary gland, unspecified
0.006 0.994 0.000
D44.0 Thyroid gland
0.006 0.994 0.000
D73.2 Chronic congestive splenomegaly
0.006 0.994 0.000
D45 Polycythaemia vera
0.006 0.994 0.000
S52.10 Fracture of upper end of radius (closed)
0.000 0.994 0.006
Z24.6 Need for immunisation against viral hepatitis
0.006 0.994 0.000
Z24.4 Need for immunisation against measles alone
0.006 0.994 0.000
Z24.3 Need for immunisation against yellow fever
0.006 0.994 0.000
Z24.2 Need for immunisation against rabies
0.006 0.994 0.000
Z24.1 Need for immunisation against arthropod-borne viral encephalitis
0.006 0.994 0.000
Z24.0 Need for immunisation against poliomyelitis
0.006 0.994 0.000
D44.8 Pluriglandular involvement
0.006 0.994 0.000
D73.8 Other diseases of spleen
0.006 0.994 0.000
S27.11 Traumatic haemothorax (with open wound into thoracic cavity)
0.006 0.994 0.000
D73.4 Cyst of spleen
0.006 0.994 0.000
C42 hematopoietic and reticuloendothelial systems (ICD-O-3 specific)
0.006 0.994 0.000
C38.4 Pleura
0.006 0.994 0.000
C76.8 Overlapping lesion of other and ill-defined sites
0.006 0.994 0.000
C76.7 Other ill-defined sites
0.006 0.994 0.000
C76.5 Lower limb
0.006 0.994 0.000
C76.4 Upper limb
0.006 0.994 0.000
S27.81 Injury of other specified intrathoracic organs (with open wound into thoracic cavity)
0.006 0.994 0.000
Y87.1 Sequelae of assault
0.006 0.994 0.000
C37 Malignant neoplasm of thymus
0.006 0.994 0.000
D42.9 Meninges, unspecified
0.006 0.994 0.000
D42.1 Spinal meninges
0.006 0.994 0.000
D42.0 Cerebral meninges
0.006 0.994 0.000
D73.1 Hypersplenism
0.006 0.994 0.000
C05.9 Palate, unspecified
0.006 0.994 0.000
C76.0 Head, face and neck
0.006 0.994 0.000
C75.9 Endocrine gland, unspecified
0.006 0.994 0.000
C75.8 Pluriglandular involvement, unspecified
0.006 0.994 0.000
C75.5 Aortic body and other paraganglia
0.006 0.994 0.000
C75.4 Carotid body
0.006 0.994 0.000
C75.3 Pineal gland
0.006 0.994 0.000
C75.2 Craniopharyngeal duct
0.006 0.994 0.000
C75.1 Pituitary gland
0.006 0.994 0.000
C75.0 Parathyroid gland
0.006 0.994 0.000
O23.4 Unspecified infection of urinary tract in pregnancy
0.006 0.994 0.000
Z20.1 Contact with and exposure to tuberculosis
0.006 0.994 0.000
D74.9 Methaemoglobinaemia, unspecified
0.006 0.994 0.000
D74.8 Other methaemoglobinaemias
0.006 0.994 0.000
D74.0 Congenital methaemoglobinaemia
0.006 0.994 0.000
C33 Malignant neoplasm of trachea
0.006 0.994 0.000
C69-C72 Malignant neoplasms of eye, brain and other parts of central nervous system
0.006 0.994 0.000
C04.8 Overlapping lesion of floor of mouth
0.006 0.994 0.000
C04.1 Lateral floor of mouth
0.006 0.994 0.000
C04.0 Anterior floor of mouth
0.006 0.994 0.000
C91.4 Hairy-cell leukaemia
0.006 0.994 0.000
D75.9 Disease of blood and blood-forming organs, unspecified
0.006 0.994 0.000
C31 Malignant neoplasm of accessory sinuses
0.006 0.994 0.000
C15 Malignant neoplasm of oesophagus
0.006 0.994 0.000
D00.1 Oesophagus
0.006 0.994 0.000
C74.1 Medulla of adrenal gland
0.006 0.994 0.000
D44.1 Adrenal gland
0.006 0.994 0.000
D73.5 Infarction of spleen
0.006 0.994 0.000
D41.9 Urinary organ, unspecified
0.006 0.994 0.000
D41.7 Other urinary organs
0.006 0.994 0.000
D41.3 Urethra
0.006 0.994 0.000
Z23.8 Need for immunisation against other single bacterial diseases
0.005 0.994 0.000
Z23.7 Need for immunisation against pertussis alone
0.005 0.994 0.000
Z23.6 Need for immunisation against diphtheria alone
0.005 0.994 0.000
Z23.5 Need for immunisation against tetanus alone
0.005 0.994 0.000
Z23.4 Need for immunisation against tularaemia
0.005 0.994 0.000
Z23.3 Need for immunisation against plague
0.005 0.994 0.000
Z23.2 Need for immunisation against tuberculosis [BCG]
0.005 0.994 0.000
Z23.1 Need for immunisation against typhoid-paratyphoid alone [TAB]
0.005 0.994 0.000
Z23.0 Need for immunisation against cholera alone
0.005 0.994 0.000
Z25.8 Need for immunisation against other specified single viral diseases
0.005 0.994 0.000
Z25.1 Need for immunisation against influenza
0.005 0.994 0.000
Z25.0 Need for immunisation against mumps alone
0.005 0.994 0.000
Z26.9 Need for immunisation against unspecified infectious disease
0.005 0.994 0.000
Z26.8 Need for immunisation against other specified single infectious diseases
0.005 0.994 0.000
Z26.0 Need for immunisation against leishmaniasis
0.005 0.994 0.000
Z27.9 Need for immunisation against unspecified combinations of infectious diseases
0.005 0.994 0.000
Z27.8 Need for immunisation against other combinations of infectious diseases
0.005 0.994 0.000
Z27.4 Need for immunisation against measles-mumps-rubella [MMR]
0.005 0.994 0.000
Z27.3 Need for immunisation against diphtheria-tetanus-pertussis with poliomyelitis [DTP + polio]
0.005 0.994 0.000
Z27.2 Need for immunisation against diphtheria-tetanus-pertussis with typhoid-paratyphoid [DTP + TAB]
0.005 0.994 0.000
Z27.1 Need for immunisation against diphtheria-tetanus-pertussis, combined [DTP]
0.005 0.994 0.000
Z27.0 Need for immunisation against cholera with typhoid-paratyphoid [cholera + TAB]
0.005 0.994 0.000
Z28.9 Immunisation not carried out for unspecified reason
0.005 0.994 0.000
Z28.8 Immunisation not carried out for other reasons
0.005 0.994 0.000
Z28.2 Immunisation not carried out because of patient's decision for other and unspecified reasons
0.005 0.994 0.000
Z28.1 Immunisation not carried out because of patient's decision for reasons of belief or group pressure
0.005 0.994 0.000
Z28.0 Immunisation not carried out because of contraindication
0.005 0.994 0.000
D04.4 Skin of scalp and neck
0.006 0.994 0.000
Z20.9 Contact with and exposure to unspecified communicable disease
0.005 0.994 0.000
Z20.7 Contact with and exposure to pediculosis, acariasis and other infestations
0.005 0.994 0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2025 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.